DHI vs. FUE Hair Transplant: Which Differences Matter?
Written by ReGrow Medical Editorial Team.
Medically reviewed by Dr. Amiel Moshfegh, M.D.
Published . Updated .
THE SHORT ANSWER
FUE describes how hair grafts are harvested. DHI usually describes how—or how soon—they are implanted. A procedure called DHI can therefore use FUE. The meaningful differences are in the placement workflow, the people performing it, and the plan for your hair—not simply the name on the package.
If one clinic recommends FUE and another recommends DHI, you may not be choosing between two entirely different operations. The International Society of Hair Restoration Surgery (ISHRS) separates FUE donor harvesting from the later implantation process.
This guide explains the distinction, examines selected published studies, and gives you a practical way to compare recommendations. It is patient education from ReGrow Medical, a hair-restoration provider—not an independent ranking of clinics or devices.
In this guide: the differences that matter
One FUE Harvest, Three Ways to Place Grafts
FUE stands for follicular unit excision: individual natural groupings of hair follicles are removed from a donor area. A graft is the tissue containing the follicles being moved; a recipient site is the opening where it will be placed. See our FUE procedure guide for the broader process.
Can be combined with any of these placement approaches
- WORKFLOW APrepared recipient sitesGrafts placed with forceps
- WORKFLOW BPrepared recipient sitesGrafts placed with an appropriate implanter
- WORKFLOW CSharp implanterCreates the opening and inserts the graft in the same action
The ISHRS explanation of implantation tools distinguishes forceps placement, dull implanters used in prepared sites, and sharp implanters that create an opening during insertion. FUE does not mean “forceps only,” and using a pen does not necessarily mean “no pre-made sites.”
What Does “Direct Hair Implantation” Actually Mean?
DHI is not used consistently. The ISHRS surgical-treatment guidance describes the term being used for prompt implantation after extraction and for placement with a sharp implanter. It does not recognize DHI as a separate harvesting method.
There is a useful example in the literature: a 2013 study by Sethi and Bansal described “direct hair transplantation” in 29 men. The team made recipient sites first, then coordinated FUE harvesting and implantation. “Direct” described the workflow; it was not proof of an entirely different way to obtain donor hair.
This matters when you hear that a pen automatically means less time outside the body. A tool name is not a timing protocol. Ask whether grafts are harvested in batches, how they are held, and when placement begins. The timing and handling need an explanation of their own.
Implanter Pens: Potential Benefits and Practical Trade-Offs
An implanter holds a graft in a channel for insertion. It can reduce direct handling of the follicle bulb during placement; a sharp version also combines site creation with insertion. Those are meaningful technical features, but they do not remove the need for skilled loading and careful use.
A 2023 practical guide by Park and colleagues describes instrument selection, placement depth, insertion technique and staff training. Its message is more specific than “a pen is better”: the way a team uses the instrument matters.
- Loading: grafts still have to be handled and positioned correctly in the device.
- Fit and control: the tip and insertion depth need to suit the graft and the treatment plan.
- Coordination: the people loading and placing grafts must work together consistently.
These considerations make implanters a technique to evaluate—not a result to assume. Prepared sites with forceps or an appropriate implanter remain distinct workflows worth understanding on their own terms.
Two instruments, two jobs: a donor punch makes the small incision around a graft during harvesting; an implantation instrument is used to place it. A donor-punch measurement is not a measurement of the recipient opening.
Does DHI Produce Better Density or Graft Survival?
The studies reviewed for this guide do not establish a universal winner between the labels “DHI” and “FUE.” They describe particular tools and workflows, often in settings that cannot isolate which part of the treatment produced the outcome.
For example, a 2019 study involving 104 patients combined FUE with implanters used in pre-made sites. It evaluated changes in a baldness-classification score. It was not a randomized comparison proving that this approach gives every patient better graft survival.
That distinction matters because these measurements answer different questions:
- Graft survival: how many transplanted grafts grow, under the study’s counting method and follow-up.
- Density or coverage: how much hair occupies an area, or how full the area looks.
- Patient satisfaction: whether the outcome meets the person’s expectations.
A photograph, satisfaction score and counted survival percentage are not interchangeable evidence. If a clinic quotes a percentage, ask which outcome it measures, in how many patients, and at what follow-up. For visual examples, our before-and-after evaluation guide explains what to compare.
A closer look at the evidence behind this comparison
- 2013 direct-transplantation series: 29 men; outcomes assessed using photographs and baldness-grade changes. It demonstrates a described workflow, not a controlled comparison of labels.
- 2019 pre-made-site study: 104 patients; the reported endpoint was change in baldness classification, not a universal survival rate.
- 2023 sharp-implanter guide: practical surgical guidance, not a head-to-head outcome trial. One author disclosed implanter patents and an ownership interest.
- 2024 implantation-tool comparison: the abstract describes four patients in four groups and measures implantation speed. That small study cannot establish broad, long-term superiority between DHI and FUE packages.
This is a focused explanation of selected sources, not a systematic review or original clinical study. The evidence supports discussing specific workflows; it does not support a blanket survival, density or recovery guarantee.
Which Differences Matter for Your Goals?
The practical decision starts with what you want to change. Use your priority to make the consultation more specific:
- A natural-looking hairline: ask to see the proposed design and how it fits your existing hair and longer-term plan—not just which device will be used.
- Coverage across a larger area: ask how the available donor supply would be allocated, and which areas take priority if that supply is limited.
- Keeping the procedure discreet: get separate answers about donor trimming, recipient hair length and visible healing.
None of these goals, by itself, identifies a winning acronym. A useful recommendation explains the trade-off in your case: what the plan can reasonably address, what it cannot, and why the proposed workflow fits.
Shaving, Recovery and Scars Are Separate Decisions
Does DHI mean no shaving? Not necessarily. The ISHRS distinguishes donor and recipient hair-length choices. FUE may involve full, partial or unshaven donor preparation. Sharp implanters can be useful around longer recipient hair, but the DHI label does not promise that all your hair will remain long. See our no-shave FUE guide.
Does DHI avoid incisions or scars? No. A sharp implanter still enters the skin. FUE harvesting also creates small donor wounds that can leave small scars. Combining placement steps does not make surgery incision-free. Ask for realistic expectations for both areas.
Is recovery automatically faster? A label alone is not enough to plan time off work, exercise or a haircut. Get instructions for your actual procedure and follow-up arrangements. Our FUE recovery guide provides general background, not individual clearance.
A Practical Example: Compare Two Proposals, Not Two Labels
Imagine you receive these two proposals for the same hairline area and the same estimated 2,000 grafts. These are hypothetical examples, not ReGrow quotes or recommendations for a particular patient.
PROPOSAL A · “FUE”
Prepared sites + forceps
FUE harvesting, with recipient sites created before graft placement using forceps.
PROPOSAL B · “DHI”
Sharp-implanter placement
FUE harvesting, with a sharp implanter creating each recipient opening as the graft is inserted.
What is shared? The stated harvesting method, target area and estimated graft count. What differs? The described site-creation and placement workflow. What is still missing? Whether the plans are equally suitable for you, who performs them, and what care is included.
| Compare this | What a useful answer contains |
|---|---|
| Personalized plan | A proposed design, treatment priorities, donor assessment and explanation of the graft estimate. |
| People and roles | Who harvests, creates sites, places grafts and provides medical oversight—with their qualifications. |
| Handling and timing | How grafts are managed between harvesting and placement, rather than only a device name. |
| Full scope of care | What the written price includes, follow-up arrangements, possible extras and who to contact after surgery. |
If one proposal costs more, ask which concrete differences explain it. A higher price is not, by itself, evidence of a better result. Keep price comparisons tied to scope; our FUE cost and quote guide covers that decision in detail.
The ReGrow Perspective: Start With the Patient
“The procedure should be designed around the patient—not around the technology.”
— Dr. Amiel Moshfegh, from his published ReGrow treatment philosophy
At ReGrow Medical, Dr. Moshfegh’s documented approach emphasizes careful tissue handling, instrument control and planning around donor supply, existing hair and future loss. He favors handheld control for FUE harvesting. That preference describes harvesting; it should not be read as a claim about a particular implantation pen or branded DHI system.
His role includes assessing the donor area, designing the hairline, leading the treatment plan and directly supervising harvesting and recipient-site creation while working with the clinical team. Ask for the proposed roles and placement workflow for your own procedure.
For patients in Los Angeles, the San Fernando Valley and elsewhere in Southern California, ReGrow offers a local starting point for that discussion through six locations. Confirm consultation availability and the location of your procedure when scheduling.
Frequently Asked Questions
Can DHI and FUE be used in the same transplant?
Yes. A procedure called DHI can use FUE to harvest grafts and then use a particular implantation workflow. The terms can describe different parts of the same treatment rather than mutually exclusive choices.
Is DHI the same as robotic FUE?
No. In “robotic FUE,” the term refers to robotic assistance with donor harvesting; it does not, by itself, identify the placement workflow. DHI generally describes placement or its timing. Handheld instruments can also be motorized, so “handheld” and “manual” are not always identical. Our harvesting-system comparison covers that separate question.
Does a DHI label tell me who performs the surgery?
No. Neither DHI nor FUE identifies the clinician or team members responsible for each step. Ask who will harvest, create recipient sites and place grafts, and how medical oversight and follow-up are provided.
Do I need to choose DHI or FUE before a consultation?
No. Bring your goals and any proposals you already have. A useful consultation should explain your options and the reasons behind a recommendation; you do not need to choose an instrument before your hair loss and donor area are assessed.
YOUR NEXT STEP
Leave With a Clearer Treatment Plan
The best next question is not simply “Which acronym wins?” It is “What will you do in my case, why is it appropriate, and who will do it?”
Request a ReGrow Medical consultation to discuss your hair-restoration goals and the details behind the recommendation.